Find Tedizolid manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

133 RELATED EXCIPIENT COMPANIES

233EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 856867-55-5, Torezolid phosphate, Tr-701fa, Tr-701 fa, Tedizolid (phosphate), Tedizolid phosphate [usan]
Molecular Formula
C17H16FN6O6P
Molecular Weight
450.3  g/mol
InChI Key
QCGUSIANLFXSGE-GFCCVEGCSA-N
FDA UNII
O7DRJ6R4DW

Tedizolid
Drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and penicillin-resistant Streptococcus penumoniae, represent a massive public health threat. Tedizolid is a member of the oxazolidinone class of antibiotics, which includes the previously approved [linezolid] and is generally effective against multidrug-resistant Gram-positive bacteria. Tedizolid is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and is generally more effective and more tolerable than [linezolid]. Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO). This product is currently available as both an oral tablet and as a powder for intravenous injection.
1 2D Structure

Tedizolid

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate
2.1.2 InChI
InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1
2.1.3 InChI Key
QCGUSIANLFXSGE-GFCCVEGCSA-N
2.1.4 Canonical SMILES
CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)COP(=O)(O)O)F
2.1.5 Isomeric SMILES
CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)COP(=O)(O)O)F
2.2 Other Identifiers
2.2.1 UNII
O7DRJ6R4DW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Da 7218

2. Da-7218

3. Da7218

4. Sivextro

5. Torezolid Phosphate

6. Tr 701

7. Tr-701

2.3.2 Depositor-Supplied Synonyms

1. 856867-55-5

2. Torezolid Phosphate

3. Tr-701fa

4. Tr-701 Fa

5. Tedizolid (phosphate)

6. Tedizolid Phosphate [usan]

7. (r)-(3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl Dihydrogen Phosphate

8. Chebi:83326

9. Tr-701-fa

10. O7drj6r4dw

11. Tr-701

12. 856867-55-5 (phosphate)

13. [(5r)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl Dihydrogen Phosphate

14. Tedizolidphosphate

15. [(5r)-3-{3-fluoro-4-[6-(2-methyl-2h-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl]methyl Dihydrogen Phosphate

16. Unii-o7drj6r4dw

17. Tedizolid-phosphate

18. Sivextro (tn)

19. Da-7218 Free Acid

20. Schembl1557561

21. Chembl2105669

22. Tedizolid Phosphate [mi]

23. Tedizolid Phosphate (jan/usan)

24. Amy9256

25. Dtxsid30234977

26. Tedizolid Phosphate [jan]

27. Tedizolid Phosphate [vandf]

28. Bcp10960

29. Ex-a5792

30. Tr-701 Free Acid Phosphate

31. Bdbm50017198

32. Da7218

33. Hy-14855b

34. Mfcd28098176

35. S4641

36. Tedizolid Phosphate [who-dd]

37. Zinc43100953

38. Akos027250820

39. Ccg-269233

40. Cs-5004

41. Db09042

42. Ncgc00482851-02

43. Tedizolid Phosphate [orange Book]

44. As-57141

45. D09686

46. Tr701-fa; Tr-701-fa; Tr 701-fa

47. A863474

48. Q21011227

49. ((5r)-3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5- Yl)methyl Hydrogen Phosphate

50. ((5r)-3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl Hydrogen Phosphate

51. 2-oxazolidinone, 3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-5- ((phosphonooxy)methyl)-, (5r)-

52. 2-oxazolidinone, 3-(3-fluoro-4-(6-(2-methyl-2h-tetrazol-5-yl)-3-pyridinyl)phenyl)-5-((phosphonooxy)methyl)-, (5r)-

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 450.3 g/mol
Molecular Formula C17H16FN6O6P
XLogP30.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count6
Exact Mass450.08529741 g/mol
Monoisotopic Mass450.08529741 g/mol
Topological Polar Surface Area153 Ų
Heavy Atom Count31
Formal Charge0
Complexity702
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Tedizolid is indicated for the treatment of acute bacterial infections of the skin and skin structure (ABSSSI). To prevent drug resistance, tedizolid should only be used for infections that are caused by susceptible bacteria.


FDA Label


Sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and adolescents 12 years of age and older.


Treatment of acute bacterial skin and skin structure infections


5 Pharmacology and Biochemistry
5.1 Pharmacology

Tedizolid is an oxazolidinone antibiotic that works by inhibiting protein synthesis by bacterial ribosomes. However, oxazolidinone antibiotics can also bind to human mitochondrial, but not cytoplasmic, ribosomes. Mitochondrial protein synthesis inhibition is associated with adverse patient effects such as neurological, hematological, and gastrointestinal toxicity, although tedizolid is tolerated better than the related [linezolid]. Alternative therapies should be considered when treating neutropenic patients with ABSSSI. _Clostridium difficile_-associated diarrhea has been reported in patients treated with tedizolid.


5.2 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]; Breast Cancer Resistance Protein Inhibitors [MoA]
5.4 ATC Code

J01XX11


5.5 Absorption, Distribution and Excretion

Absorption

Tedizolid reaches peak plasma concentrations within three hours for oral administration and within one hour following intravenous administration; the absolute oral bioavailability is approximately 91%. Food has no effect on absorption. When given once daily, either orally or intravenously, tedizolid reaches steady-state concentrations in approximately three days. The Cmax for tedizolid after a single dose/at steady-state is 2.0 0.7/2.2 0.6 mcg/mL for oral administration, and 2.3 0.6/3.0 0.7 mcg/mL for intravenous administration, respectively. Similarly, the Tmax has a median (range) of 2.5 (1.0 - 8.0)/3.5 (1.0 - 6.0) hrs for the oral route and 1.1 (0.9 - 1.5)/1.2 (0.9 - 1.5) hrs when given intravenous. The AUC is 23.8 6.8/25.6 8.4 mcg\*hr/mL for oral and 26.6 5.2/29.2 6.2 mcg\*hr/mL for intravenous.


Route of Elimination

When given as a single oral dose, approximately 82% of tedizolid is excreted via the feces and 18% in urine. The majority is found as the inactive sulphate conjugate, with only 3% recovered unchanged. Over 85% of the elimination occurs within 96 hours.


Volume of Distribution

The volume of distribution for tedizolid following a single intravenous dose of 200 mg is between 67 and 80 L. In a study involving oral administration of 200 mg tedizolid to steady-state, the volume of distribution was 108 21 L, while a single 600 mg oral dose resulted in an apparent volume of distribution of 113.3 19.3 L. Tedizolid has been observed to penetrate the interstitial space of both adipose and skeletal muscle tissue and is also found in the epithelial lining fluid as well as in alveolar macrophages.


Clearance

Tedizolid has an apparent oral clearance of 6.9 1.7 L/hr for a single dose and 8.4 2.1 L/hr at steady-state. The systemic clearance is 6.4 1.2 L/hr for a single dose and 5.9 1.4 L/hr at steady-state.


5.6 Metabolism/Metabolites

Tedizolid is administered as a phosphate prodrug that is converted to tedizolid (the circulating active moiety). Prior to excretion, the majority of tedizolid is converted to an inactive sulphate conjugate in the liver, though this is unlikely to involve the action of cytochrome P450-family enzymes.


5.7 Biological Half-Life

Tedizolid has a half-life of approximately 12 hours.


5.8 Mechanism of Action

Despite renewed efforts to combat the spread of antimicrobial resistance, multidrug-resistant organisms, including gram-positive bacteria such as methicillin-resistant _Staphylococcus aureus_, remain a threat. Oxazolidinones represent a relatively new class of antibacterials inhibiting protein synthesis that is generally capable of overcoming resistance to other bacterial protein synthesis inhibitors. Protein synthesis involves the action of ribosomes, multi-subunit complexes composed of both protein and ribosomal RNA (rRNA) substituents. Translocation along the length of a messenger RNA and concomitant protein synthesis involves the action of the A, P, and E sites of the peptidyltransferase centre (PTC), which accepts charged aminoacyl-tRNAs and catalyzes the formation of peptide bonds between them. The bacterial 70S ribosome comprises a small (30S) and a large (50S) subunit. Early studies into the mechanism of action of oxazolidinone antibiotics suggested that they inhibit a step in the initiation of protein synthesis. However, this mechanism was inconsistent with mapped resistance mutations, and later studies involving cross-linking and direct structural determination of the binding site revealed that oxazolidinones, including both [linezolid] and tedizolid, bind in the A site of the PTC by interacting with the 23S rRNA component. The structural studies also revealed that oxazolidinone binding alters the conformation of a conserved nucleotide in the 23S rRNA (U2585 in _Escherichia coli_), which renders the PTC non-productive for peptide bond formation. Hence, tedizolid exerts its effect through inhibiting bacterial protein synthesis.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Tedizolid

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Tedizolid

About the Company :

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

03

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid Phosphate

About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...

Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine chemicals and fundamental chemical materials. It has an efficient research and development team. Beijing Mesochem provides its customers customized development, craft optimization, contract customization and outsourcing services. The company has a well-established industrial base in Weinan, Shanxi Province. The production base features a 20,000 ㎡ plant with a production capacity of over 8,000 MT per year.
blank

04

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid Phosphate

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

05

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Torezolid Phosphate

About the Company : Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical interm...

Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical intermediates and new drugs. The company is mainly engaged in customized synthesis of complex small molecule frameworks and pharmaceutical intermediates, and independent R&D of innovative new drugs; and provides services of production technology improvement and consigned new drug development for pharmaceutical enterprises. Haoyuan Chemexpress is committed to researching and developing APIs and pharmaceutical intermediates with high synthesis technology barriers and difficulties and high added value, and also focuses on the synthesis of chiral compounds.
blank

06

Hetero Drugs

India
Compamed
Not Confirmed
arrow

Hetero Drugs

India
arrow
Compamed
Not Confirmed

Tedizolid

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

07

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid

About the Company : Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kim...

Kimia Biosciences, established in 1993, is focused on manufacturing bulk drugs for various therapeutic segments. With a strong emphasis on excellence and advanced technologies, Kimia aims to become a globally recognized company in both APIs and FDFs while upholding clean business practices. Kimia's state-of-the-art facilities at Village Bhondsi, Gurugram enable it to produce a wide range of APIs. Kimia also plans to establish its own facilities for lifestyle segments, adhering to international regulatory standards. Kimia aims to provide the best pharmaceutical products and support to consumers and healthcare professionals.
blank

08

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid

About the Company : Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global mar...

Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global markets. Our aim from day one has been to provide and ensure better healthcare across the globe through our research, Innovations, affordable products & manufacturing excellence. Optimus was established to provide quality & affordable pharmaceutical products in the global markets.
blank

09

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid

About the Company : Shandong Hao Hong Biotechnology Co., Ltd. is located in Provincial Chemical Industrial Park of Liaocheng city, Shandong province, which is a beautiful water city. And recently anot...

Shandong Hao Hong Biotechnology Co., Ltd. is located in Provincial Chemical Industrial Park of Liaocheng city, Shandong province, which is a beautiful water city. And recently another production plant in Hebei Shijiazhuang chemical industry park will be put into operation too. Our company focused on the development and production of pharmaceutical products, with 30 sets of 50L to 5000L reactor, and the annual manufacturing capacity could be 500 tons. We had advanced sewage treatment system, with the daily processing capacity of 1000 tons. Our team focus on developing the anti-cancer, anti-HCV and anti-diabetes series of APIs etc.
blank

10

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Tedizolid

About the Company : Viruj Pharmaceuticals, an India-based company with a global presence, aims to develop & market complex, technology-driven APIs. It offers contract API manufacturing for innovative ...

Viruj Pharmaceuticals, an India-based company with a global presence, aims to develop & market complex, technology-driven APIs. It offers contract API manufacturing for innovative companies globally, & APIs for generic companies. Viruj Pharmaceuticals adheres to quality systems defined in Schedule M, Schedule L, ICH Q7 & TRS guidelines & leads in process validation, cleaning validation, analytical method transfers & process technology. It ensures GMP compliance at its facility. Viruj seeks to develop APIs via continuous Flow Technology & has invested in the requisite infrastructure for developing APIs using Flow Chemistry techniques.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"TEDIZOLID PHOSPHATE","year":"2021","qtr":"Q1","strtotime":1614882600,"product":"TEDIZOLID PHOSPHATE IN-HOUSE","address":"4-7-101 SCIENTIST COLONY,HABSIGUDA","city":"HYDERABAD, TELANGANA","supplier":"OPTRIX LABORATORIES PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"HIKMA PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"29.56","actualQuantity":"29.56","unit":"KGS","unitRateFc":"6003.9","totalValueFC":"175642","currency":"USD","unitRateINR":432577.26657645468,"date":"05-Mar-2021","totalValueINR":"12786984","totalValueInUsd":"175642","indian_port":"HYDERABAD AIR","hs_no":"29419090","bill_no":"9132136","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"4-7-101 SCIENTIST COLONY,HABSIGUDA, HYDERABAD, TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1631644200,"product":"TEDIZOLID PHOSPHATE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (CAIRO)","customer":"MARCYRL PHARMACEUTICAL INDUSTRISTRIES","customerCountry":"EGYPT","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"4785.2","totalValueFC":"94004.2","currency":"USD","unitRateINR":345730.70000000001,"date":"15-Sep-2021","totalValueINR":"6914614","totalValueInUsd":"94004.2","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29339990","bill_no":"4002140","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"TEDIZOLID PHOSPHATE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (CAIRO)","customer":"MARCYRL PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"4830","totalValueFC":"191304.8","currency":"USD","unitRateINR":373117.5,"date":"18-Jun-2022","totalValueINR":"14924700","totalValueInUsd":"191304.8","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29339990","bill_no":"4001507","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"ARSHIYA-SEZ\/PANVEL","supplierAddress":"B-4, IDA,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692901800,"product":"TEDIZOLID PHOSPHATE IHS","address":"7-1-638 TO 643 643\/1FLAT NO. 302 BHANU ENCLAVE ERRAGADDA","city":"Hyderabad","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"NA","customer":"TO THE ORDER OF","customerCountry":"MEXICO","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7420.9","totalValueFC":"7363.9","currency":"USD","unitRateINR":610000.03500000003,"date":"25-Aug-2023","totalValueINR":"610000.035","totalValueInUsd":"7363.9","indian_port":"HYDERABAD ICD","hs_no":"29419090","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"7-1-638 TO 643 643\/1FLAT NO. 302 BHANU ENCLAVE ERRAGADDA, Hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728585000,"product":"TEDIZOLID PHOSPHATE API (LUT NO : ARN- AD080324021302P \/2024-25 DT. 19-03-2024)","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"PSK PHARMA LTD.","customerCountry":"RUSSIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"799000","totalValueFC":"9378","currency":"INR","unitRateINR":788000,"date":"11-Oct-2024","totalValueINR":"788000","totalValueInUsd":"9378","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4765336","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652207400,"product":"TEDIZOLID PHOSPHATE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"HANGZHOU QICHUANG CHEMICAL","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"VIRUPAKSHA ORGANICS","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"4350","totalValueFC":"173469.3","currency":"USD","unitRateINR":"335167.5","date":"11-May-2022","totalValueINR":"13406700","totalValueInUsd":"173469.3","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29339990","bill_no":"1008328","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"ROOM 1204, NINGBO MANSION, NO.46 TI ANMUSHAN ROAD,XIHU DISTRICT,HANGZHO U ZHEJIANG CHINA POSTCODE 310007 CHINA","customerAddress":"B-4, IDA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655922600,"product":"TEDIZOLID PHOSPHATE","address":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA","city":"HYDERABAD,TELANGANA","supplier":"TAIZHOU CRENE BIOTECHNOLOGY CO,LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"METROCHEM API PRIVATE LIMITED","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"4550","totalValueFC":"4604.5","currency":"USD","unitRateINR":"359222.5","date":"23-Jun-2022","totalValueINR":"359222.5","totalValueInUsd":"4604.5","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"9237663","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661970600,"product":"PHARMACEUTICALS RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG - TEDIZOLID PHOSPHATE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"HANGZHOU QICHUANG CHEMICAL","supplierCountry":"CHINA","foreign_port":"N\/A","customer":"VIRUPAKSHA ORGANICS","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"4350","totalValueFC":"174779.3","currency":"USD","unitRateINR":"350175","date":"01-Sep-2022","totalValueINR":"14007000","totalValueInUsd":"174779.3","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29332990","bill_no":"1015687","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"ROOM 1204 NINGBO MANSION ZHEJIANG CHINA CN","customerAddress":"B-4, IDA,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664476200,"product":"PHARMACEUTICALS RAW MATERIAL FOR MFG OF INTERMEDIATE BULK DRUG - TEDIZOLID PHOSPHATE","address":"B-4, IDA,","city":"HYDERABAD, TELANGANA.","supplier":"HANGZHOU QICHUANG CHEMICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"VIRUPAKSHA ORGANICS","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"4500","totalValueFC":"13543.6","currency":"USD","unitRateINR":"361800","date":"30-Sep-2022","totalValueINR":"1085400","totalValueInUsd":"13543.6","indian_port":"ARSHIYA-SEZ\/PANVEL","hs_no":"29332990","bill_no":"1017529","productDescription":"Intermediate","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"N\/A","customerAddress":"B-4, IDA,"}]
05-Mar-2021
11-Oct-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Coating Systems & Additives

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Lubricants & Glidants

read-more
read-more

Taste Masking

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Coloring Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty